305 filings
Page 5 of 16
CORRESP
SBFM
Sunshine Biopharma Inc
7 Apr 22
Correspondence with SEC
12:00am
S-3
SBFM
Sunshine Biopharma Inc
30 Mar 22
Shelf registration
5:20pm
8-K
SBFM
Sunshine Biopharma Inc
24 Mar 22
Other Events
4:15pm
10-K
2021 FY
SBFM
Sunshine Biopharma Inc
Annual report
21 Mar 22
7:46am
D
SBFM
Sunshine Biopharma Inc
18 Mar 22
$8M in equity / options, sold $8M, 9 investors
7:58am
8-K
SBFM
Sunshine Biopharma Inc
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
SBFM
Sunshine Biopharma Inc
25 Feb 22
Sunshine Biopharma Expands Anti-coronavirus Drug Development Program by Signing a Collaboration Agreement with the University of Arizona
8:00am
4
SBFM
Sunshine Biopharma Inc
22 Feb 22
Sunshine Biopharma / Steve N. Slilaty ownership change
1:07pm
3
David Natan
18 Feb 22
Sunshine Biopharma / DAVID NATAN ownership change
3:25pm
3
SBFM
Sunshine Biopharma Inc
18 Feb 22
Sunshine Biopharma / Andrew Mark Keller ownership change
3:25pm
8-K
SBFM
Sunshine Biopharma Inc
17 Feb 22
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
10:25am
424B4
SBFM
Sunshine Biopharma Inc
17 Feb 22
Prospectus supplement with pricing info
6:00am
EFFECT
SBFM
Sunshine Biopharma Inc
15 Feb 22
Notice of effectiveness
12:15am
S-1/A
SBFM
Sunshine Biopharma Inc
IPO registration (amended)
14 Feb 22
6:01am
CERT
SBFM
Sunshine Biopharma Inc
11 Feb 22
Certification of approval for exchange listing
12:00am
8-K
SBFM
Sunshine Biopharma Inc
10 Feb 22
Amendments to Articles of Incorporation or Bylaws
3:13pm
8-A12B
SBFM
Sunshine Biopharma Inc
10 Feb 22
Registration of securities on exchange
1:02pm
S-1/A
SBFM
Sunshine Biopharma Inc
IPO registration (amended)
9 Feb 22
5:03pm
CORRESP
SBFM
Sunshine Biopharma Inc
9 Feb 22
Correspondence with SEC
12:00am
CORRESP
SBFM
Sunshine Biopharma Inc
9 Feb 22
Correspondence with SEC
12:00am